Published in Antimicrob Agents Chemother on August 01, 1989
beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev (1995) 12.53
Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns. Antimicrob Agents Chemother (2003) 0.93
ACI-1 from Acidaminococcus fermentans: characterization of the first beta-lactamase in Anaerobic cocci. Antimicrob Agents Chemother (2000) 0.93
Purification and characterization of a new beta-lactamase from Bacteroides uniformis. Antimicrob Agents Chemother (1995) 0.81
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol (1973) 25.78
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
A spectrophotometric assay of beta-lactamase action on penicillins. Biochem J (1974) 7.26
A direct spectrophotometric assay and determination of Michaelis constants for the beta-lactamase reaction. Anal Biochem (1975) 5.15
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrob Agents Chemother (1976) 4.64
Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother (1980) 3.48
Bacteroides penicillinase. J Bacteriol (1968) 3.10
Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibiotics. Antimicrob Agents Chemother (1975) 3.09
Beta-lactamase activity in anaerobic bacteria. Antimicrob Agents Chemother (1976) 2.75
Outbreak of necrotising enterocolitis caused by Clostridium butyricum. Lancet (1977) 2.50
Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27
Purification and properties of beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother (1978) 1.71
Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother (1981) 1.63
Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus. J Antibiot (Tokyo) (1983) 1.32
Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother (1985) 1.15
Characteristics of a beta-lactamase produced by Clostridium butyricum. J Antimicrob Chemother (1982) 1.09
Purification by affinity chromatography and properties of a beta-lactamase isolated from Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 1.00
Some properties of the Clostridium butyricum group beta-lactamase. J Gen Microbiol (1981) 0.85
Evaluation of five test-kits-API, AuxoTab, Enterotube, PathoTec and R-B-for identification of Enterobacteriaceae. Med Microbiol Immunol (1974) 8.61
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrob Agents Chemother (1976) 4.64
Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis (2001) 4.17
Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis Suppl (1979) 2.66
Evaluation of coli-count samplers for possible use in standard couting of total and fecal coliforms in recreational waters. Appl Microbiol (1975) 2.49
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother (2001) 2.35
Evaluation of two test-kits--API and Oxi Ferm tube--for identification of oxidative-fermentative Gram-negative rods. Med Microbiol Immunol (1977) 2.31
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis (1985) 2.16
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.15
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis (1997) 2.02
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis (1993) 1.92
Acetamide agar medium selective for Pseudomonas aeruginosa. Appl Microbiol (1969) 1.90
Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg (1995) 1.76
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Glycosyl transferases of O-antigen biosynthesis in Salmonella enterica: identification and characterization of transferase genes of groups B, C2, and E1. J Bacteriol (1993) 1.74
Rapid grouping of streptococci by immunoelectroosmophoresis. Med Microbiol Immunol (1974) 1.67
Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants. Infection (1987) 1.66
Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother (1982) 1.65
Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl (1999) 1.62
Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis (1979) 1.61
Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis (1974) 1.57
The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Acta Paediatr Scand (1985) 1.56
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol (1977) 1.55
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis (1975) 1.54
Aspects on antibacterial treatment of anaerobic infections. Scand J Infect Dis Suppl (1982) 1.53
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother (1999) 1.52
Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J Antimicrob Chemother (1981) 1.52
In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol (1974) 1.47
Probiotics and gastrointestinal diseases. J Intern Med (2005) 1.47
Chronic meningitis caused by a penicillin-sensitive microorganism? Lancet (1983) 1.46
Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother (1980) 1.45
Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob Agents Chemother (1992) 1.45
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol (1998) 1.40
[Is it time to reintroduce remedial classes? Let us offer better chances to children with MBD/DAMP!]. Lakartidningen (1995) 1.39
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis (2001) 1.37
Resistance to beta-lactam antibiotics in Bacteroides species. J Antimicrob Chemother (1981) 1.36
Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother (1974) 1.35
Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med (1984) 1.34
The normal human anaerobic microflora. Scand J Infect Dis Suppl (1982) 1.33
Detection and quantitation by lysis-filtration of bacteremia after different oral surgical procedures. J Clin Microbiol (1990) 1.32
In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline. Clin Microbiol Infect (2000) 1.31
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect (2009) 1.31
In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics. Scand J Infect Dis (1974) 1.29
Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis (1986) 1.28
Numerical taxonomy and laboratory identification of Actinomyces and Arachnia and some related bacteria. J Gen Microbiol (1975) 1.27
Serological studies of Actinomyces israelii by crossed immunoelectrophoresis: taxonomic and diagnostic applications. Infect Immun (1975) 1.27
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis (2000) 1.27
Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol (1980) 1.26
Effect of cefoperazone on faecal flora. J Antimicrob Chemother (1983) 1.26
Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1989) 1.26
Norfloxacin binds to human fecal material. Antimicrob Agents Chemother (1988) 1.25
The role of Bacteroides fragilis in the pathogenesis of acute appendicitis. Acta Chir Scand (1982) 1.25
Antibiotic susceptibility of Clostridium species isolated from human infections. Scand J Infect Dis (1975) 1.25
Characterization of three Aeromonas and nine pseudomonas species by extracellular enzymes and haemolysins. Med Microbiol Immunol (1975) 1.22
European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect (2005) 1.22
Muscle morphology, enzymatic activity, and muscle strength in elderly men: a follow-up study. Muscle Nerve (1986) 1.21
Bilophila wadsworthia isolates from clinical specimens. J Clin Microbiol (1992) 1.21
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience. Rev Infect Dis (1985) 1.20
Characterization of the DNA of a Nonoccluded Baculovirus, Hz-1V. J Virol (1982) 1.19
Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection (1985) 1.18
Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. J Gen Microbiol (1976) 1.17
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1998) 1.16
The kinetics of conformational changes in hemoglobin, studied by laser photolysis. Proc Natl Acad Sci U S A (1974) 1.16
In vitro activity of HMR 3647 against anaerobic bacteria. J Chemother (1998) 1.16
Some properties of coagulase-negative deoxyribonuclease-producing strains of staphylococci from human infections. Med Microbiol Immunol (1976) 1.16
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect (2003) 1.16
Ligature wires and elastomeric rings: two methods of ligation, and their association with microbial colonization of Streptococcus mutans and lactobacilli. Eur J Orthod (1991) 1.16
Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother (1985) 1.15
Anaerobic bacteria in late infections following orthopedic surgery. Med Microbiol Immunol (1979) 1.15
Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A. J Gen Microbiol (1974) 1.14
Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis. J Antimicrob Chemother (1992) 1.14
Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol (1983) 1.13
Effect of quinolones on intestinal ecology. Drugs (1999) 1.13
Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens. Toxicon (1973) 1.13
Comparison of bacteriophage typing, serotyping, and biotyping as aids in epidemiological surveillance of Klebsiella infections. J Clin Microbiol (1978) 1.12
Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora. Eur J Clin Invest (1988) 1.11
Transferases of O-antigen biosynthesis in Salmonella enterica: dideoxyhexosyltransferases of groups B and C2 and acetyltransferase of group C2. J Bacteriol (1995) 1.11
Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother (1981) 1.10
Excited-state dynamics of fully reduced flavins and flavoenzymes studied at subpicosecond time resolution. Photochem Photobiol (1998) 1.10
Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J Antimicrob Chemother (2000) 1.09
Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.09
Lactobacilli and the normal human anaerobic microflora. Clin Infect Dis (1993) 1.09
Characterization of a new beta-lactamase from Fusobacterium nucleatum by substrate profiles and chromatofocusing patterns. J Antimicrob Chemother (1985) 1.08
Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine. J Clin Psychopharmacol (2001) 1.08
Impaired muscle function with aging. A background factor in the incidence of fractures of the proximal end of the femur. Clin Orthop Relat Res (1984) 1.07
Betalactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis Suppl (1983) 1.07
Salpingitis; aspects of diagnosis and etiology: a 4-year study from a Swedish capital hospital. Eur J Obstet Gynecol Reprod Biol (1987) 1.05